CA2453366C - Methods, apparatus, and computer programs for verifying the integrity of a probe - Google Patents
Methods, apparatus, and computer programs for verifying the integrity of a probe Download PDFInfo
- Publication number
- CA2453366C CA2453366C CA2453366A CA2453366A CA2453366C CA 2453366 C CA2453366 C CA 2453366C CA 2453366 A CA2453366 A CA 2453366A CA 2453366 A CA2453366 A CA 2453366A CA 2453366 C CA2453366 C CA 2453366C
- Authority
- CA
- Canada
- Prior art keywords
- probe
- temperature
- fluorescence
- signal
- target
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000000523 sample Substances 0.000 title claims abstract description 816
- 238000000034 method Methods 0.000 title claims abstract description 101
- 238000004590 computer program Methods 0.000 title abstract description 22
- 150000007523 nucleic acids Chemical class 0.000 claims abstract description 104
- 102000039446 nucleic acids Human genes 0.000 claims abstract description 82
- 108020004707 nucleic acids Proteins 0.000 claims abstract description 82
- 238000000137 annealing Methods 0.000 claims description 124
- 239000000203 mixture Substances 0.000 claims description 120
- 230000003321 amplification Effects 0.000 claims description 88
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 88
- 238000006243 chemical reaction Methods 0.000 claims description 78
- 238000010791 quenching Methods 0.000 claims description 56
- 230000000171 quenching effect Effects 0.000 claims description 52
- 239000003795 chemical substances by application Substances 0.000 claims description 40
- 230000008859 change Effects 0.000 claims description 37
- 238000009396 hybridization Methods 0.000 claims description 35
- 108091033319 polynucleotide Proteins 0.000 claims description 25
- 102000040430 polynucleotide Human genes 0.000 claims description 25
- 239000002157 polynucleotide Substances 0.000 claims description 25
- 230000027455 binding Effects 0.000 claims description 23
- 230000000694 effects Effects 0.000 claims description 15
- 238000010438 heat treatment Methods 0.000 claims description 13
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 claims description 12
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 claims description 12
- 108091034117 Oligonucleotide Proteins 0.000 claims description 12
- 108020005187 Oligonucleotide Probes Proteins 0.000 claims description 9
- 108010010677 Phosphodiesterase I Proteins 0.000 claims description 9
- 239000002751 oligonucleotide probe Substances 0.000 claims description 9
- 230000002829 reductive effect Effects 0.000 claims description 9
- 239000013615 primer Substances 0.000 description 57
- 238000001514 detection method Methods 0.000 description 47
- 238000003752 polymerase chain reaction Methods 0.000 description 46
- 238000003556 assay Methods 0.000 description 43
- 238000012360 testing method Methods 0.000 description 41
- 239000000047 product Substances 0.000 description 40
- 238000002866 fluorescence resonance energy transfer Methods 0.000 description 33
- 230000007246 mechanism Effects 0.000 description 31
- 239000011541 reaction mixture Substances 0.000 description 27
- 238000005259 measurement Methods 0.000 description 24
- 108091028043 Nucleic acid sequence Proteins 0.000 description 21
- 108020004414 DNA Proteins 0.000 description 18
- 239000000975 dye Substances 0.000 description 18
- 239000007850 fluorescent dye Substances 0.000 description 12
- 230000000295 complement effect Effects 0.000 description 11
- 238000001816 cooling Methods 0.000 description 11
- 238000000862 absorption spectrum Methods 0.000 description 10
- 238000009825 accumulation Methods 0.000 description 10
- 238000010606 normalization Methods 0.000 description 10
- 239000003153 chemical reaction reagent Substances 0.000 description 9
- 230000003993 interaction Effects 0.000 description 9
- 238000011088 calibration curve Methods 0.000 description 8
- 238000003753 real-time PCR Methods 0.000 description 8
- 238000004891 communication Methods 0.000 description 7
- 238000000295 emission spectrum Methods 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 238000012986 modification Methods 0.000 description 7
- 230000004048 modification Effects 0.000 description 7
- 102000004190 Enzymes Human genes 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 6
- 238000003776 cleavage reaction Methods 0.000 description 6
- 238000007899 nucleic acid hybridization Methods 0.000 description 6
- 239000013641 positive control Substances 0.000 description 6
- 230000007017 scission Effects 0.000 description 6
- 238000002944 PCR assay Methods 0.000 description 5
- 108091093037 Peptide nucleic acid Proteins 0.000 description 5
- 230000009102 absorption Effects 0.000 description 5
- 230000000692 anti-sense effect Effects 0.000 description 5
- 230000002860 competitive effect Effects 0.000 description 5
- 125000003729 nucleotide group Chemical group 0.000 description 5
- 230000006903 response to temperature Effects 0.000 description 5
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 4
- 238000006073 displacement reaction Methods 0.000 description 4
- 238000007834 ligase chain reaction Methods 0.000 description 4
- 239000011159 matrix material Substances 0.000 description 4
- 239000003068 molecular probe Substances 0.000 description 4
- 239000002773 nucleotide Substances 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- WCKQPPQRFNHPRJ-UHFFFAOYSA-N 4-[[4-(dimethylamino)phenyl]diazenyl]benzoic acid Chemical compound C1=CC(N(C)C)=CC=C1N=NC1=CC=C(C(O)=O)C=C1 WCKQPPQRFNHPRJ-UHFFFAOYSA-N 0.000 description 3
- -1 DNA Chemical class 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 230000002255 enzymatic effect Effects 0.000 description 3
- 230000007274 generation of a signal involved in cell-cell signaling Effects 0.000 description 3
- 239000002853 nucleic acid probe Substances 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 238000011002 quantification Methods 0.000 description 3
- 238000004445 quantitative analysis Methods 0.000 description 3
- 230000002285 radioactive effect Effects 0.000 description 3
- 238000013518 transcription Methods 0.000 description 3
- 230000035897 transcription Effects 0.000 description 3
- QEQDLKUMPUDNPG-UHFFFAOYSA-N 2-(7-amino-4-methyl-2-oxochromen-3-yl)acetic acid Chemical compound C1=C(N)C=CC2=C1OC(=O)C(CC(O)=O)=C2C QEQDLKUMPUDNPG-UHFFFAOYSA-N 0.000 description 2
- SJQRQOKXQKVJGJ-UHFFFAOYSA-N 5-(2-aminoethylamino)naphthalene-1-sulfonic acid Chemical compound C1=CC=C2C(NCCN)=CC=CC2=C1S(O)(=O)=O SJQRQOKXQKVJGJ-UHFFFAOYSA-N 0.000 description 2
- 102000053602 DNA Human genes 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- 108010066717 Q beta Replicase Proteins 0.000 description 2
- 108091028664 Ribonucleotide Proteins 0.000 description 2
- 241000239226 Scorpiones Species 0.000 description 2
- 108010006785 Taq Polymerase Proteins 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- 238000002441 X-ray diffraction Methods 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 238000004737 colorimetric analysis Methods 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 230000000875 corresponding effect Effects 0.000 description 2
- 230000001351 cycling effect Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- VYXSBFYARXAAKO-UHFFFAOYSA-N ethyl 2-[3-(ethylamino)-6-ethylimino-2,7-dimethylxanthen-9-yl]benzoate;hydron;chloride Chemical compound [Cl-].C1=2C=C(C)C(NCC)=CC=2OC2=CC(=[NH+]CC)C(C)=CC2=C1C1=CC=CC=C1C(=O)OCC VYXSBFYARXAAKO-UHFFFAOYSA-N 0.000 description 2
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 2
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 230000005389 magnetism Effects 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 229940046166 oligodeoxynucleotide Drugs 0.000 description 2
- 230000010076 replication Effects 0.000 description 2
- 238000012340 reverse transcriptase PCR Methods 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 2
- 239000002336 ribonucleotide Substances 0.000 description 2
- 238000005096 rolling process Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- VQTBINYMFPKLQD-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) 2-(3-hydroxy-6-oxoxanthen-9-yl)benzoate Chemical compound C=12C=CC(=O)C=C2OC2=CC(O)=CC=C2C=1C1=CC=CC=C1C(=O)ON1C(=O)CCC1=O VQTBINYMFPKLQD-UHFFFAOYSA-N 0.000 description 1
- VQRBXYBBGHOGFT-UHFFFAOYSA-N 1-(chloromethyl)-2-methylbenzene Chemical compound CC1=CC=CC=C1CCl VQRBXYBBGHOGFT-UHFFFAOYSA-N 0.000 description 1
- GOLORTLGFDVFDW-UHFFFAOYSA-N 3-(1h-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one Chemical compound C1=CC=C2NC(C3=CC4=CC=C(C=C4OC3=O)N(CC)CC)=NC2=C1 GOLORTLGFDVFDW-UHFFFAOYSA-N 0.000 description 1
- QCPFFGGFHNZBEP-UHFFFAOYSA-N 4,5,6,7-tetrachloro-3',6'-dihydroxyspiro[2-benzofuran-3,9'-xanthene]-1-one Chemical compound O1C(=O)C(C(=C(Cl)C(Cl)=C2Cl)Cl)=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 QCPFFGGFHNZBEP-UHFFFAOYSA-N 0.000 description 1
- NJYVEMPWNAYQQN-UHFFFAOYSA-N 5-carboxyfluorescein Chemical compound C12=CC=C(O)C=C2OC2=CC(O)=CC=C2C21OC(=O)C1=CC(C(=O)O)=CC=C21 NJYVEMPWNAYQQN-UHFFFAOYSA-N 0.000 description 1
- YERWMQJEYUIJBO-UHFFFAOYSA-N 5-chlorosulfonyl-2-[3-(diethylamino)-6-diethylazaniumylidenexanthen-9-yl]benzenesulfonate Chemical compound C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=C(S(Cl)(=O)=O)C=C1S([O-])(=O)=O YERWMQJEYUIJBO-UHFFFAOYSA-N 0.000 description 1
- BZTDTCNHAFUJOG-UHFFFAOYSA-N 6-carboxyfluorescein Chemical compound C12=CC=C(O)C=C2OC2=CC(O)=CC=C2C11OC(=O)C2=CC=C(C(=O)O)C=C21 BZTDTCNHAFUJOG-UHFFFAOYSA-N 0.000 description 1
- OCGLKKKKTZBFFJ-UHFFFAOYSA-N 7-(aminomethyl)chromen-2-one Chemical compound C1=CC(=O)OC2=CC(CN)=CC=C21 OCGLKKKKTZBFFJ-UHFFFAOYSA-N 0.000 description 1
- 239000012099 Alexa Fluor family Substances 0.000 description 1
- QCMYYKRYFNMIEC-UHFFFAOYSA-N COP(O)=O Chemical class COP(O)=O QCMYYKRYFNMIEC-UHFFFAOYSA-N 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- 239000003155 DNA primer Substances 0.000 description 1
- 230000006820 DNA synthesis Effects 0.000 description 1
- 206010071602 Genetic polymorphism Diseases 0.000 description 1
- 101710163270 Nuclease Proteins 0.000 description 1
- 108020004711 Nucleic Acid Probes Proteins 0.000 description 1
- 239000012807 PCR reagent Substances 0.000 description 1
- 108010076504 Protein Sorting Signals Proteins 0.000 description 1
- 108091081021 Sense strand Proteins 0.000 description 1
- 241000193990 Streptococcus sp. 'group B' Species 0.000 description 1
- RYYWUUFWQRZTIU-UHFFFAOYSA-N Thiophosphoric acid Chemical class OP(O)(S)=O RYYWUUFWQRZTIU-UHFFFAOYSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 150000004775 coumarins Chemical class 0.000 description 1
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 1
- SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 1
- RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 1
- HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 1
- NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 239000005547 deoxyribonucleotide Substances 0.000 description 1
- 125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
- 230000001687 destabilization Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000009088 enzymatic function Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 230000005281 excited state Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 244000052637 human pathogen Species 0.000 description 1
- 238000007901 in situ hybridization Methods 0.000 description 1
- 238000012296 in situ hybridization assay Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000012035 limiting reagent Substances 0.000 description 1
- DLBFLQKQABVKGT-UHFFFAOYSA-L lucifer yellow dye Chemical compound [Li+].[Li+].[O-]S(=O)(=O)C1=CC(C(N(C(=O)NN)C2=O)=O)=C3C2=CC(S([O-])(=O)=O)=CC3=C1N DLBFLQKQABVKGT-UHFFFAOYSA-L 0.000 description 1
- 238000007403 mPCR Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000013610 patient sample Substances 0.000 description 1
- 150000008298 phosphoramidates Chemical class 0.000 description 1
- 108060006184 phycobiliprotein Proteins 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 239000001022 rhodamine dye Substances 0.000 description 1
- 125000002652 ribonucleotide group Chemical group 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- MPLHNVLQVRSVEE-UHFFFAOYSA-N texas red Chemical compound [O-]S(=O)(=O)C1=CC(S(Cl)(=O)=O)=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 MPLHNVLQVRSVEE-UHFFFAOYSA-N 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
- G16B25/20—Polymerase chain reaction [PCR]; Primer or probe design; Probe optimisation
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B5/00—ICT specially adapted for modelling or simulations in systems biology, e.g. gene-regulatory networks, protein interaction networks or metabolic networks
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
- Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
- Y10T436/143333—Saccharide [e.g., DNA, etc.]
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Theoretical Computer Science (AREA)
- Evolutionary Biology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Medical Informatics (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- General Engineering & Computer Science (AREA)
- Physiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Investigating Or Analyzing Materials By The Use Of Ultrasonic Waves (AREA)
- Tests Of Electronic Circuits (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/906,897 US7226732B2 (en) | 2001-07-16 | 2001-07-16 | Methods, apparatus, and computer programs for verifying the integrity of a probe |
| US09/906,897 | 2001-07-16 | ||
| PCT/US2002/022728 WO2003009100A2 (en) | 2001-07-16 | 2002-07-16 | Methods, apparatuses, and computer programs for verifying the integrity of a probe |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2453366A1 CA2453366A1 (en) | 2003-01-30 |
| CA2453366C true CA2453366C (en) | 2013-04-16 |
Family
ID=25423168
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2453366A Expired - Lifetime CA2453366C (en) | 2001-07-16 | 2002-07-16 | Methods, apparatus, and computer programs for verifying the integrity of a probe |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US7226732B2 (OSRAM) |
| EP (1) | EP1415152B1 (OSRAM) |
| JP (4) | JP4392240B2 (OSRAM) |
| AT (1) | ATE508360T1 (OSRAM) |
| AU (1) | AU2002355109B2 (OSRAM) |
| CA (1) | CA2453366C (OSRAM) |
| DE (1) | DE60239940D1 (OSRAM) |
| ES (1) | ES2365699T3 (OSRAM) |
| WO (1) | WO2003009100A2 (OSRAM) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7226732B2 (en) | 2001-07-16 | 2007-06-05 | Cepheid | Methods, apparatus, and computer programs for verifying the integrity of a probe |
| WO2006039293A2 (en) * | 2004-09-29 | 2006-04-13 | University Of Virginia Patent Foundation | Localized control of thermal properties on microdevices and applications thereof |
| US8056881B2 (en) | 2004-10-13 | 2011-11-15 | University Of Virginia Patent Foundation | Electrostatic actuation for management of flow in micro-total analysis systems (μ-TAS) and related method thereof |
| US8084260B2 (en) * | 2004-11-24 | 2011-12-27 | Applied Biosystems, Llc | Spectral calibration method and system for multiple instruments |
| JP4922185B2 (ja) * | 2004-12-22 | 2012-04-25 | ユニバーシティ・オブ・ヴァージニア・パテント・ファウンデーション | マイクロデバイスまたはナノスケールデバイスにおける熱用途または非熱用途のためのマイクロ波の使用 |
| US8343755B2 (en) * | 2005-08-01 | 2013-01-01 | University Of Virginia Patent Foundation | Microdevices for chemical sensing and chemical actuation |
| EP1938425A4 (en) * | 2005-08-23 | 2010-09-15 | Univ Virginia | PASSIVE COMPONENTS FOR MICROFLUIDIC FLOW PROFILE FORMATION AND METHOD THEREOF |
| WO2007041671A2 (en) * | 2005-10-04 | 2007-04-12 | University Of Virginia Patent Foundation | Microchip-based acoustic trapping or capture of cells for forensic analysis and related method thereof |
| US8916375B2 (en) * | 2005-10-12 | 2014-12-23 | University Of Virginia Patent Foundation | Integrated microfluidic analysis systems |
| US20070207490A1 (en) * | 2006-03-06 | 2007-09-06 | Applera Corporation | Method and system for generating sample plate layout for validation |
| WO2007114338A1 (ja) | 2006-03-31 | 2007-10-11 | Takeda Pharmaceutical Company Limited | 酸分泌抑制薬 |
| JP2008180677A (ja) * | 2007-01-26 | 2008-08-07 | Konica Minolta Medical & Graphic Inc | マイクロチップ検査システム、マイクロチップ検査装置及びプログラム |
| FR2922897B1 (fr) * | 2007-10-25 | 2009-11-27 | Bio Rad Pasteur | Mesure d'une population d'acides nucleiques,en particulier par pcr en temps reel. |
| US10662474B2 (en) | 2010-01-19 | 2020-05-26 | Verinata Health, Inc. | Identification of polymorphic sequences in mixtures of genomic DNA by whole genome sequencing |
| EP3006573B1 (en) | 2010-01-19 | 2018-03-07 | Verinata Health, Inc | Methods for determining fraction of fetal nucleic acids in maternal samples |
| US9323888B2 (en) | 2010-01-19 | 2016-04-26 | Verinata Health, Inc. | Detecting and classifying copy number variation |
| US8700341B2 (en) | 2010-01-19 | 2014-04-15 | Verinata Health, Inc. | Partition defined detection methods |
| US9260745B2 (en) | 2010-01-19 | 2016-02-16 | Verinata Health, Inc. | Detecting and classifying copy number variation |
| US20120100548A1 (en) * | 2010-10-26 | 2012-04-26 | Verinata Health, Inc. | Method for determining copy number variations |
| WO2011090556A1 (en) | 2010-01-19 | 2011-07-28 | Verinata Health, Inc. | Methods for determining fraction of fetal nucleic acid in maternal samples |
| US10388403B2 (en) | 2010-01-19 | 2019-08-20 | Verinata Health, Inc. | Analyzing copy number variation in the detection of cancer |
| EP2588629B1 (en) | 2010-06-30 | 2017-05-17 | Gen-Probe Incorporated | Method and apparatus for identifying analyte-containing samples using single-read determination of analyte and process control signals |
| DK2697392T3 (en) | 2011-04-12 | 2016-03-29 | Verinata Health Inc | SOLUTION OF GENOME FRACTIONS USING Polymorphism COUNTS |
| US9411937B2 (en) | 2011-04-15 | 2016-08-09 | Verinata Health, Inc. | Detecting and classifying copy number variation |
| US9987576B2 (en) | 2012-12-10 | 2018-06-05 | University Of Virginia Patent Foundation | Frequency-based filtering of mechanical actuation using fluidic device |
| GB201403076D0 (en) * | 2014-02-21 | 2014-04-09 | ALERE TECHNOLOGIES GmbH | Methods for detecting multiple nucleic acids in a sample |
| LT3204517T (lt) * | 2014-10-10 | 2021-11-25 | Rutgers, The State University Of New Jersey | Polimerazės grandininės reakcijos pradmenys ir zondai, skirti mycobacterium tuberculosis |
| US20190093155A1 (en) * | 2017-05-25 | 2019-03-28 | Roche Molecular Systems, Inc. | Multiplex Nucleic Acid Amplification Assay |
| US11667945B2 (en) | 2017-08-28 | 2023-06-06 | Shizuoka Prefecture Public University Corporation | Detection method and detection probe for colibactin and colibactin-producing bacteria |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| AU653712B2 (en) * | 1990-02-16 | 1994-10-13 | F. Hoffmann-La Roche Ag | Improvements in the specificity and convenience of the polymerase chain reaction |
| US5627032A (en) * | 1990-12-24 | 1997-05-06 | Ulanovsky; Levy | Composite primers for nucleic acids |
| US5994056A (en) | 1991-05-02 | 1999-11-30 | Roche Molecular Systems, Inc. | Homogeneous methods for nucleic acid amplification and detection |
| NZ333135A (en) | 1996-06-04 | 2000-02-28 | Univ Utah Res Found | Systems and methods for monitoring for DNA amplification by fluorescence using acceptor fluorophore labeled nucleic acid probe and a donor fluorophore labeled nucleic acid probe which hybridise to adjacent regions of a target sequence |
| DK1179600T3 (da) | 1996-06-04 | 2005-09-05 | Univ Utah Res Found | Overvågning af hybridisering under PCR |
| US5736333A (en) | 1996-06-04 | 1998-04-07 | The Perkin-Elmer Corporation | Passive internal references for the detection of nucleic acid amplification products |
| US5866336A (en) * | 1996-07-16 | 1999-02-02 | Oncor, Inc. | Nucleic acid amplification oligonucleotides with molecular energy transfer labels and methods based thereon |
| US5863736A (en) * | 1997-05-23 | 1999-01-26 | Becton, Dickinson And Company | Method, apparatus and computer program products for determining quantities of nucleic acid sequences in samples |
| US5952202A (en) | 1998-03-26 | 1999-09-14 | The Perkin Elmer Corporation | Methods using exogenous, internal controls and analogue blocks during nucleic acid amplification |
| US6312929B1 (en) | 2000-12-22 | 2001-11-06 | Cepheid | Compositions and methods enabling a totally internally controlled amplification reaction |
| US7226732B2 (en) * | 2001-07-16 | 2007-06-05 | Cepheid | Methods, apparatus, and computer programs for verifying the integrity of a probe |
-
2001
- 2001-07-16 US US09/906,897 patent/US7226732B2/en not_active Expired - Lifetime
-
2002
- 2002-07-16 CA CA2453366A patent/CA2453366C/en not_active Expired - Lifetime
- 2002-07-16 ES ES02752409T patent/ES2365699T3/es not_active Expired - Lifetime
- 2002-07-16 JP JP2003514378A patent/JP4392240B2/ja not_active Expired - Lifetime
- 2002-07-16 AT AT02752409T patent/ATE508360T1/de not_active IP Right Cessation
- 2002-07-16 EP EP02752409A patent/EP1415152B1/en not_active Expired - Lifetime
- 2002-07-16 DE DE60239940T patent/DE60239940D1/de not_active Expired - Lifetime
- 2002-07-16 AU AU2002355109A patent/AU2002355109B2/en not_active Expired
- 2002-07-16 WO PCT/US2002/022728 patent/WO2003009100A2/en not_active Ceased
-
2007
- 2007-04-26 US US11/740,846 patent/US9206470B2/en not_active Expired - Lifetime
- 2007-04-26 US US11/740,834 patent/US9464317B2/en not_active Expired - Fee Related
-
2009
- 2009-02-24 JP JP2009040061A patent/JP5328412B2/ja not_active Expired - Lifetime
-
2013
- 2013-06-07 JP JP2013120613A patent/JP5955274B2/ja not_active Expired - Lifetime
-
2016
- 2016-03-25 JP JP2016061354A patent/JP6434930B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| US9206470B2 (en) | 2015-12-08 |
| US9464317B2 (en) | 2016-10-11 |
| JP2013188228A (ja) | 2013-09-26 |
| JP2009165475A (ja) | 2009-07-30 |
| JP5955274B2 (ja) | 2016-07-20 |
| ATE508360T1 (de) | 2011-05-15 |
| WO2003009100A3 (en) | 2003-11-27 |
| ES2365699T3 (es) | 2011-10-10 |
| JP5328412B2 (ja) | 2013-10-30 |
| AU2002355109B2 (en) | 2007-05-31 |
| EP1415152A4 (en) | 2005-03-23 |
| JP2005515404A (ja) | 2005-05-26 |
| US20030064368A1 (en) | 2003-04-03 |
| DE60239940D1 (de) | 2011-06-16 |
| EP1415152A2 (en) | 2004-05-06 |
| JP2016154550A (ja) | 2016-09-01 |
| JP4392240B2 (ja) | 2009-12-24 |
| US7226732B2 (en) | 2007-06-05 |
| US20070259362A1 (en) | 2007-11-08 |
| WO2003009100A2 (en) | 2003-01-30 |
| US20080227090A1 (en) | 2008-09-18 |
| EP1415152B1 (en) | 2011-05-04 |
| CA2453366A1 (en) | 2003-01-30 |
| JP6434930B2 (ja) | 2018-12-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9464317B2 (en) | Methods, apparatus, and computer programs for verifying the integrity of a probe | |
| AU2002355109A1 (en) | Methods, apparatuses, and computer programs for verifying the integrity of a probe | |
| AU743543B2 (en) | Fluorimetric detection system of a nucleic acid | |
| CA2321185C (en) | Method for detection of target nucleic acids using pcr | |
| CA2256457C (en) | Passive internal references for the detection of nucleic acid amplification products | |
| US6534645B2 (en) | Compositions and methods enabling a totally internally controlled amplification reaction | |
| US20100227326A1 (en) | Detection System | |
| EP2379741B1 (en) | Method for detecting a target nucleic acid in a sample | |
| KR100653156B1 (ko) | 복수 분석물의 결정 방법 | |
| US20080286798A1 (en) | Controls for primers in multiplex amplification reactions | |
| JP2001515734A (ja) | 非競合的共増幅法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKEX | Expiry |
Effective date: 20220718 |